Trial intelligence / Profile preview

EV06 for Presbyopia

NCT02516306Phase 2Completed

Sponsor
Encore Vision Inc.
Start
Sep 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lipoic acid choline ester in presbyopia, sponsored by Encore Vision Inc.. Started Sep 2015; status: completed.

02

Drugs

lipoic acid choline ester
03

Conditions

presbyopia

Beyond the preview

Go deeper on NCT02516306.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02516306.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call